AdaptHealth Corp.
AHCONasdaqHealthcare · Services-Home Health Care Services · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $3.24B | $3.26B | $3.20B | $2.97B | $2.45B | $1.06B |
| Operating income | $90.9M | $263.7M | −$598.4M | $190.4M | $225.6M | $71.3M |
| Net income | −$70.8M | $90.4M | −$678.9M | $69.3M | $156.2M | −$161.6M |
| Total assets | $4.32B | $4.49B | $4.51B | $5.22B | $5.25B | $1.81B |
| Total liabilities | $2.79B | $2.91B | $3.04B | $3.06B | $3.18B | $1.53B |
| Equity | $1.52B | $1.57B | $1.46B | $2.15B | $2.06B | $354.9M |
| EPS (diluted) | $-0.52 | $0.61 | $-5.31 | $0.33 | $0.67 | $-3.08 |
| Shares out. | 134.9M | 132.9M | 135.5M | 133.9M | 133.8M | 52.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 2.8%
- Net margin
- −2.2%
- Return on equity
- −4.7%
- Return on assets
- −1.6%
- Return on capital (ROCE)
- 2.5%
- Liabilities / assets
- 64.6%
- Debt / equity
- 1.84×
- Book value / share
- $11.26
- Revenue growth (YoY)
- −0.5%
- Net income growth (YoY)
- −178.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 0.26distress
- Accruals / assets
- −15.6%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 2 warning● 3 good- Altman Z″ in the distress zone
- Reported a net loss
- Revenue declined year-over-year
- Operating margin is positive
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Mcfadden Daniel EdwardOfficer — Chief Operating Officer | May 27, 2026 | Grant | 20,134 | $0.00 |
| Cashin Richard M Jr10% owner | Mar 19, 2026 | Buy | 727 | $9.94 |
| Prast Albert A.Officer — Chief Technology Officer | Mar 13, 2026 | Option exercise | 89,451 | $4.38 |
| Cashin Richard M Jr10% owner | Mar 10, 2026 | Buy | 820,528 | $9.73 |
| Weaver Susan TDirector | Mar 5, 2026 | Gift | 73,472 | $0.00 |
| Wolf Dale BDirector | Feb 27, 2026 | Buy | 8,000 | $8.96 |
| Rew Richard W. IiOfficer — CLO and General Counsel | Feb 26, 2026 | Buy | 5,000 | $8.91 |
| Rew Richard W. IiOfficer — CLO and General Counsel | Jan 30, 2026 | Grant | 53,688 | $0.00 |
| Schuster Iii Russell E.Officer — Chief Commercial Officer | Jan 30, 2026 | Grant | 48,807 | $0.00 |
| Barnhart Toby ScottOfficer — Chief Operating Officer | Jan 30, 2026 | Grant | 68,330 | $0.00 |
| Prast Albert A.Officer — Chief Technology Officer | Jan 30, 2026 | Grant | 63,449 | $0.00 |
| Mcfadden Daniel EdwardOfficer — Chief Business Systems Officer | Jan 30, 2026 | Grant | 29,284 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 7.2M | 3.8 | -9.9% |
| Apr 30, 2026 | 8.0M | 6.5 | -0.6% |
| Apr 15, 2026 | 8.0M | 7.5 | -3.7% |
| Mar 31, 2026 | 8.3M | 5.1 | -8.0% |
| Mar 13, 2026 | 9.0M | 5.1 | +22.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Director / officer changeMay 5, 2026
- Entered a material agreement · Terminated a material agreement · New financial obligation · Regulation FD disclosureApr 13, 2026
- Results of operationsFeb 24, 2026
- Results of operationsNov 4, 2025
- Results of operationsAug 5, 2025
- Regulation FD disclosureAug 5, 2025
- Regulation FD disclosureJun 30, 2025
- Shareholder voteJun 20, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-K/AFORM 8-K/AJun 2, 2026
- 144Jun 1, 2026
- 4OWNERSHIP DOCUMENTMay 29, 2026
- 10-QMay 5, 2026
- 8-KMay 5, 2026
- 4/AOWNERSHIP DOCUMENTApr 28, 2026
- ARSApr 28, 2026
- DEF 14AApr 28, 2026
- 8-KApr 13, 2026
- SCHEDULE 13GApr 9, 2026
- 4/AMar 30, 2026
- 4/AMar 30, 2026
- SCHEDULE 13G/AMar 26, 2026
- 4Mar 23, 2026
- 4OWNERSHIP DOCUMENTMar 16, 2026
Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.